Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul 8;58(1):2101090.
doi: 10.1183/13993003.01090-2021. Print 2021 Jul.

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls

David Montani  1   2   3 , Laurent Savale  1   2   3 , Antoine Beurnier  1   2   4 , Romain Colle  1   5 , Nicolas Noël  1   6 , Tài Pham  1   7 , Xavier Monnet  1   2   7 , Marc Humbert  1   2   3
Affiliations
Editorial

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls

David Montani et al. Eur Respir J. .

Abstract

The importance of the COVID-19 pandemic requires us to break down the walls between medical specialties to optimise the management of patients with post-acute COVID-19 syndrome https://bit.ly/3gzqEik

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: D. Montani reports grants and personal fees from Actelion and Bayer, grants, personal fees and non-financial support from MSD, personal fees from GSK, Pfizer, Chiesi, Boehringer and Incyte Biosciences France, non-financial support from Acceleron, outside the submitted work. Conflict of interest: L. Savale has nothing to disclose. Conflict of interest: A. Beurnier reports personal fees from Sanofi, outside the submitted work. Conflict of interest: R. Colle has nothing to disclose. Conflict of interest: N. Noël has nothing to disclose. Conflict of interest: T. Pham has nothing to disclose. Conflict of interest: X. Monnet has nothing to disclose. Conflict of interest: M. Humbert reports grants and personal fees from Actelion and Bayer, personal fees from Acceleron, GSK, Merck, Novartis, AstraZeneca and Sanofi, outside the submitted work.

References

    1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard . Date last accessed: 10 Apr 2021. https://covid19.who.int
    1. Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA 2021; 325: 1829–1830. doi:10.1001/jama.2021.5469 - DOI - PMC - PubMed
    1. Chalmers JD, Crichton ML, Goeminne PC, et al. . Management of hospitalised adults with coronavirus disease-19 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2021; 57: 2100048. doi:10.1183/13993003.00048-2021 - DOI - PMC - PubMed
    1. Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021; 27: 601–615. doi:10.1038/s41591-021-01283-z - DOI - PMC - PubMed
    1. Wise J. Long covid: WHO calls on countries to offer patients more rehabilitation. BMJ 2021; 372: n405. doi:10.1136/bmj.n405 - DOI - PubMed

Publication types